Article-processing charge discount for AORTIC members

Infectious Agents and Cancer are proudly affiliated with the African Organization for Research and Training in Cancer (AORTIC). All members of AORTIC receive a 15% discount on the article-processing charge for each article accepted for publication. This discount can be requested during the submission process and will be verified before being applied. Standard waiver rules apply for low-income countries.

Featured: AORTIC position statement

The African Organization for Research and Training in Cancer (AORTIC) publishes a critical appraisal of the state on cancer research and cancer care in Africa including information on the availability of data on cancer burden, screening and prevention for cancer in Africa, cancer care personnel, treatment modalities, and access to cancer care.

Tweets

Editors-in-Chief

Aims and scope

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical and translational research providing an insight into the association between chronic infections and cancer.

The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:

• HPV and anogenital cancers, as well as head and neck cancers;• EBV and Burkitt lymphoma;• HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;• HHV8 and Kaposi sarcoma;• HTLV and leukemia;• Cancers in Low- and Middle-income countries.

There are established links between specific chronic infections and cancer. Recent advances in genomic and proteomic technologies have accelerated the discovery of novel pathogens, cancer antigens and the molecular pathways involved in disease progression. Several new fields are developing very rapidly, in particular the application of immunogenomics and pharmacogenomics to fight specific cancers, targeting immuno-tolerated cellular/viral molecules by immuno and drug therapy. Infectious Agents and Cancer covers all these areas of biomedical research and any other topics pertinent to the development of therapies for chronic infections and cancer.

Editors' quotes

“Cancers related to infectious diseases represent a very significant component of the cancer burden in humans spanning from 20% of all malignancies in industrialized countries to 40% in developing countries. Studies on pathogen-related cancers allow the identification of mechanisms relevant to oncogenesis as well as molecular markers for diagnostic/prognostic methods and targets for therapeutic strategies. Furthermore their relevance is due to the concrete possibility of preventive strategies, which are always cost-effective and can usually be implemented with relatively modest investments. The open access policy of Infectious Agents and Cancer represents a key factor to foster an even participation and contribution by Western as well as Eastern/Southern Countries' colleagues.”

“Cancer is the leading cause of death worldwide. The International Agency for Research on Cancer estimates that about 20% of cancers in developed countries and close to 30% of cancers in developing countries have an infectious etiology. These statistics articulate the imperative to study the epidemiology, biology, and response to treatment of infection-associated cancers to establish sound evidence-based approaches to cancer public policy, prevention, and treatment. The open access policy of Infectious Agents and Cancer represents a key component in the broad efforts to foster, accelerate, and reduce disparity in access to scientific information by scientists, public health authorities, and policy markers worldwide.”